Amivantamab, the first epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with penile and inguinal ulcers and paronychia

Saved in:

Bibliographic Details
Main Authors:	Karina J. Cancel-Artau, MD (Author), Angélica C. Marrero-Pérez, MD (Author), Eduardo A. Michelén-Gómez, MD (Author), Xavier Sánchez-Flores, MD (Author)
Format:	Book
Published:	Elsevier, 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Item Description:	2352-5126 10.1016/j.jdcr.2024.01.014

Similar Items